Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of colistin sulfate in ICU patients
ChiCTR2400094485Phase 4Not yet recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- Dec 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of colistin in Gram-negative bacterial infection, sponsored by Chinese PLA General Hospital. Primary endpoints: Plasma concentration of colistin sulfate, Serum biochemistry and 4 more. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
colistin
03
Conditions
Gram-negative bacterial infection
Beyond the preview
Go deeper on ChiCTR2400094485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400094485.